Julie M. Vose, MD, MBA | Authors


Exploring Novel Agents to Target Pathways in Lymphoma

August 09, 2018

Julie M. Vose, MD, MBA, Chief in the Division of Oncology/Hematology at the University of Nebraska Medical Center, discusses strategies for overcoming resistance in lymphoma during the 2018 Pan Pacific Lymphoma Conference.